CS logo
small CS logo
Urology Department, Sun Yet-Sen University Cancer Center

Guangzhou, Guangdong, China

About Urology Department, Sun Yet-Sen University Cancer Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Total Rows: 1

Clinical Trials at Urology Department, Sun Yet-Sen University Cancer Center


During the past decade, Urology Department, Sun Yet-Sen University Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
2007-08-01
2017-09-07
Completed
674
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
2009-08-25
2021-04-29
Completed
492

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 2Pfizer: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Urology Department, Sun Yet-Sen University Cancer Center


According to Clinical.Site data, the most researched conditions in "Urology Department, Sun Yet-Sen University Cancer Center" are "Kidney Neoplasms" (2 trials). Many other conditions were trialed in "Urology Department, Sun Yet-Sen University Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Urology Department, Sun Yet-Sen University Cancer Center


Most popular intervention types in "Urology Department, Sun Yet-Sen University Cancer Center" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Axitinib (AG-013736)" (1 trials), "Placebo" (1 trials), "Sorafenib" (1 trials) and "Sunitinib malate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Urology Department, Sun Yet-Sen University Cancer Center


The vast majority of trials in "Urology Department, Sun Yet-Sen University Cancer Center" are 2 trials for "All" genders.

Clinical Trials Status at Urology Department, Sun Yet-Sen University Cancer Center


Currently, there are NaN active trials in "Urology Department, Sun Yet-Sen University Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Urology Department, Sun Yet-Sen University Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Urology Department, Sun Yet-Sen University Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2